Quinn Opportunity Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-110,113
| Closed | -$571K | – | 387 |
|
|
2024
Q3 | $571K | Buy |
110,113
+100,113
| +1,001% | +$520K | 0.06% | 177 |
|
|
2024
Q2 | $25.7K | Hold |
10,000
| – | – | ﹤0.01% | 265 |
|
|
2024
Q1 | $49.2K | Hold |
10,000
| – | – | 0.01% | 233 |
|
|
2023
Q4 | $87.9K | Buy |
+10,000
| New | +$87.9K | 0.01% | 205 |
|
|
2020
Q3 | – | Sell |
-15,200
| Closed | -$371K | – | 223 |
|
|
2020
Q2 | $371K | Hold |
15,200
| – | – | 0.05% | 142 |
|
|
2020
Q1 | $225K | Sell |
15,200
-41,572
| -73% | -$615K | 0.03% | 140 |
|
|
2019
Q4 | $921K | Buy |
56,772
+3,372
| +6% | +$54.7K | 0.11% | 98 |
|
|
2019
Q3 | $694K | Buy |
53,400
+728
| +1% | +$9.46K | 0.08% | 106 |
|
|
2019
Q2 | $683K | Sell |
52,672
-4,000
| -7% | -$51.9K | 0.08% | 111 |
|
|
2019
Q1 | $893K | Hold |
56,672
| – | – | 0.12% | 87 |
|
|
2018
Q4 | $1.14M | Sell |
56,672
-2,000
| -3% | -$40.3K | 0.16% | 66 |
|
|
2018
Q3 | $1.46M | Buy |
58,672
+25,572
| +77% | +$635K | 0.21% | 73 |
|
|
2018
Q2 | $909K | Buy |
33,100
+24,000
| +264% | +$659K | 0.12% | 98 |
|
|
2018
Q1 | $280K | Hold |
9,100
| – | – | 0.04% | 152 |
|
|
2017
Q4 | $325K | Buy |
+9,100
| New | +$325K | 0.05% | 138 |
|